Dr. Reddy's Laboratories launches Fesoterodine Fumarate Extended-Release Tablets

09 Jul 2022 Evaluate

Dr. Reddy's Laboratories along with its subsidiaries together have launched Fesoterodine Fumarate Extended-Release Tablets, a therapeutic generic equivalent to Toviaz (fesoterodine fumarate) Extended-Release Tablets in the U.S. market following the approval by the U.S. Food and Drug Administration (USFDA).

The Toviaz brand had U.S. sales of approximately $211 million MAT for the most recent twelve months ending in May 2022. Dr. Reddy’s Fesoterodine Fumarate Extended-Release Tablets are available in 4 mg and 8 mg Tablets, each in bottle count sizes of 30.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1281.30 -37.60 (-2.85%)
27-Feb-2026 12:55 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1764.75
Dr. Reddys Lab 1281.30
Cipla 1344.00
Zydus Lifesciences 920.45
Lupin 2305.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×